RXAuditor Joins Bluesight
Bluesight’s acquisition of Medacist combines two innovators in drug diversion analytics and medication management solutions that together will serve more than 1,600 hospitals across North America. Bluesight’s advanced auditing capabilities and visibility across all hospital care areas complement Medacist’s streamlined reporting and visibility tools across the health system. Healthcare organizations will have a single source of software solutions that provides insights into medication usage and diversion to allow for the most accurate predictions, targeted interventions and, ultimately, improved patient outcomes.
Supporting Patient Safety Through Drug Diversion Prevention
The opioid epidemic isn’t going away, and Bluesight is here to help. With over 24 years of data and analytics experience, we have proven solutions to help healthcare organizations identify drug diversion with speed, accuracy, and confidence.

Experience Matters
Take the Guesswork Out of Drug Diversion Prevention
Lean on data-driven insights and our suite of future-forward products to implement drug diversion solutions that deliver results.
-
Drug Diversion Prevention
Drug Diversion PreventionActionable information. Practical Solutions.
Learn MoreProvide system-wide accountability with how medications are dispensed and tracked throughout the medication lifecycle. Through our industry-leading experience, streamlining data of potential diverters allows healthcare workers to give time back to those at the heart of their facilities – patients.
-
Medication Reconciliation
Medication ReconciliationFaster, near-real-time accountability
Learn MoreBuilt on stronger data to deliver unparalleled insights, Bluesight’s RxAuditor Reconcile closes the loop on the medication use process. Standardized collaborative workflows for drug diversion investigations have the ability to quickly identify anomalous activity.
Actionable information. Practical Solutions.
Provide system-wide accountability with how medications are dispensed and tracked throughout the medication lifecycle. Through our industry-leading experience, streamlining data of potential diverters allows healthcare workers to give time back to those at the heart of their facilities – patients.

Faster, near-real-time accountability
Built on stronger data to deliver unparalleled insights, Bluesight’s RxAuditor Reconcile closes the loop on the medication use process. Standardized collaborative workflows for drug diversion investigations have the ability to quickly identify anomalous activity.



RxAuditor Investigate is an improved communication tool for the multidisciplinary teams and allows those teams to come to a quicker resolution when outliers are identified.”

RxAuditor Investigate does a fantastic job of taking the top high-risk users of controlled substances in our facility and displays them in an easy to view diversion risk dashboard. To research diversion is a needle in a haystack, but with RxAuditor Investigate it brings that haystack down to a more manageable size.”

I love the visual aspects of RxAuditor Investigate. I find the assurance metrics section to be exceptionally helpful by comparing the user to their peers. I would like to give RxAuditor Investigate credit for the “aha moment”.”

RxAuditor Investigate is a very user friendly application that helps prioritize avenues to investigate for drug diversion. It makes a very daunting task much more manageable. RxAuditor Investigate captures an immense amount of data, and it provides guidance on how to utilize the data. Any organization that needs help in the prevention/detection of diversion should demo RxAuditor Investigate. The staff and support team are very knowledgeable and helpful.”